» Articles » PMID: 15100685

Represcription of Penicillin After Allergic-like Events

Overview
Date 2004 Apr 22
PMID 15100685
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: We sought to determine the frequency of represcription of penicillin to individuals with penicillin allergy and the risk of a second reaction in those who had a previous reaction.

Methods: A retrospective cohort study was conducted within the UK General Practice Research Database. All patients who had received a prescription for penicillin were identified. Within that source population, records of patients who had received at least 2 prescriptions for penicillin at least 60 days apart were selected and examined for allergic-like (hypersensitivity) events on the day of or within 30 days after a prescription.

Results: At least one prescription for penicillin was given to 3,375,162 patients. Of 6212 (0.18%) patients who experienced an allergic-like event after the initial prescription, 48.5% were given a second prescription compared with 59.8% of those without an initial allergic-like event (risk ratio, 0.81; 95% CI, 0.79-0.83). Two or more prescriptions for penicillin were given to 2,017,957 patients. Three thousand fourteen (0.15%) patients experienced an allergic-like event after the first prescription, and 57 (1.89%) of those had another event after the second prescription. The unadjusted odds ratio of an allergic-like event after the second prescription for those who experienced an allergic-like event after the first prescription, compared with those who had no initial event was 11.2 (95% CI, 8.6-14.6). Adjusting for confounding had no substantive effect on this result.

Conclusion: The risk of an allergic-like event after penicillin is markedly increased in those who have had a prior event, although the absolute difference is small (1.72%). Represcription of penicillin to such patients is more frequent than anticipated.

Citing Articles

Analysis of Allergy and Hypersensitivity Reactions to COVID-19 Vaccines According to the EudraVigilance Database.

Romantowski J, Nazar W, Bojahr K, Popiolek I, Niedoszytko M Life (Basel). 2024; 14(6).

PMID: 38929698 PMC: 11205009. DOI: 10.3390/life14060715.


The Use of Electronic Health Records to Study Drug-Induced Hypersensitivity Reactions from 2000 to 2021: A Systematic Review.

Bassir F, Varghese S, Wang L, Chin Y, Zhou L Immunol Allergy Clin North Am. 2022; 42(2):453-497.

PMID: 35469629 PMC: 9267416. DOI: 10.1016/j.iac.2022.01.004.


Safety of benzathine penicillin for preventing congenital syphilis: a systematic review.

Galvao T, Silva M, Serruya S, Newman L, Klausner J, Pereira M PLoS One. 2013; 8(2):e56463.

PMID: 23437138 PMC: 3578834. DOI: 10.1371/journal.pone.0056463.


Epidemiology and cost analysis of pharmacist interventions at Ghent University Hospital.

Claus B, Vandeputte F, Robays H Int J Clin Pharm. 2012; 34(5):773-8.

PMID: 22810891 DOI: 10.1007/s11096-012-9676-5.


Lives Saved Tool supplement detection and treatment of syphilis in pregnancy to reduce syphilis related stillbirths and neonatal mortality.

Blencowe H, Cousens S, Kamb M, Berman S, Lawn J BMC Public Health. 2011; 11 Suppl 3:S9.

PMID: 21501460 PMC: 3231915. DOI: 10.1186/1471-2458-11-S3-S9.